By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Intranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.
This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.
Pharmacists play a key role in the management of modern monoclonal antibody treatments for Alzheimer disease.
Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.
Panelists discuss the evolving management of RSV, highlighting the importance of increasing awareness and education, anticipating advances in testing, data reporting, and treatment options like monoclonal antibodies and antivirals, and considering future vaccination strategies such as booster doses to enhance prevention and patient outcomes.
The future of vancomycin dosing lies in optimizing dosing regimens to individual patient needs.
An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
NK is a degenerative corneal disease resulting from diminished corneal innervation.
This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.
This short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.
True patient centricity treats the whole patient and places an emphasis on broader patient engagement and satisfaction.
Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.
Systemic treatment options have historically been limited to traditional chemotherapy agents.
Pharmacy teams are learning to adapt to the challenges of limited distribution networks and orphan drug designation in oncology, with integrated pharmacy support playing a crucial role in enhancing patient access and adherence.
Indications for adalimumab include ankylosing spondylitis, Crohn disease, chronic plaque psoriasis, juvenile idiopathic arthritis, moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
It is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.
Vaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.
Investigators assessed fixed-duration venetoclax plus acalabrutinib with or without obinutuzumab vs chemoimmunotherapy.
The RESCUE BT2 trial sheds further light on the agent’s potential.
Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.
The opportunity to provide non-invasive colorectal cancer screening and education to patients is undoubtedly a role that pharmacists can fill.
Abigail Thomas, PharmD, and Lee A. Kral, PharmD, discuss the evolving role of psilocybin-assisted therapy in palliative care, highlighting current evidence, safety concerns, and how pharmacists can guide patient selection, manage drug interactions, and support education as the therapy moves closer to clinical use.
Throat indications contribute to high antibiotic overprescribing rates.